Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You? [Yahoo! Finance]
CRISPR Therapeutics AG - Common Shares (CRSP)
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/symbol/crsp/real-time
Company Research
Source: Yahoo! Finance
Businesses like that tend to have volatile and temperamental stocks, though investors are lured back time and time again because they offer the possibility of big returns in exchange for significant risks. Does it make sense to invest in these stocks when the market is dumping them? Cathie Wood is buying the dip on two biotechs in particular, so for her, the answer to that question in this case is a "yes." Let's analyze whether it might make sense for you to follow her purchases, too. 1. CRISPR Therapeutics With its shares down by 13% this year, CRISPR Therapeutics (NASDAQ: CRSP) is a certainly a candidate for buying the dip. Among her frequent purchases of it this month, Wood last bought the stock on May 30; it represents 3.6% of the Ark Invest portfolio, making it the eighth-largest investment across all of the related funds. The company is a natural fit for Wood's investing goals, which emphasize businesses pursuing technologies, strategies, or products capable of disruptin
Show less
Read more
Impact Snapshot
Event Time:
CRSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRSP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRSP alerts
High impacting CRISPR Therapeutics AG - Common Shares news events
Weekly update
A roundup of the hottest topics
CRSP
News
- Exsilio Therapeutics Launches with $82 Million Series A Financing to Develop Redosable Genomic Medicines for A Broad Range of Diseases [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to Note [Yahoo! Finance]Yahoo! Finance
- CRISPR and Cas Genes Market Research 2024 - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics Stock (NASDAQ:CRSP): Will It Take Off Anytime Soon? [Yahoo! Finance]Yahoo! Finance
- Global Genome Editing Market Size, Share & Trends Analysis Report by Technology (CRISPR/Cas9, ZFN), Delivery Method (Ex-vivo, In-vivo) 2024-2030 [Yahoo! Finance]Yahoo! Finance
CRSP
Earnings
- 5/9/24 - Beat
CRSP
Sec Filings
- 6/24/24 - Form 4
- 6/3/24 - Form 8-K
- 5/31/24 - Form 4
- CRSP's page on the SEC website